• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Quoin Pharmaceuticals Shares Jumped By More Than 44%; Here Are 57 Biggest Movers From Yesterday

    10/19/22 5:10:26 AM ET
    $ACOR
    $AGFY
    $AKUS
    $AUID
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Farming/Seeds/Milling
    Consumer Staples
    Get the next $ACOR alert in real time by email

    Gainers

    • COMSovereign Holding Corp. (NASDAQ:COMS) shares jumped 170.1% to close at $0.1194 on Tuesday after gaining 4% on Monday.
    • Akouos, Inc. (NASDAQ:AKUS) shares surged 88.2% to close at $13.19 on Tuesday. Eli Lilly And Co (NYSE:LLY) agreed to acquire Akouos for a 78% premium over Monday’s closing price of $7.01.
    • Rubicon Technologies, Inc. (NYSE:RBT) climbed 58.2% to close at $1.74.
    • Helbiz, Inc. (NASDAQ:HLBZ) climbed 58.1% to close at $0.4211. Helbiz CEO Salvatore Palella recently acquired a total of 200,000 shares at an average price of $0.25.
    • Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) jumped 44.4% to close at $2.73 after the company announced plans to initiate a second clinical trial in Netherton Syndrome patients.
    • AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) gained 42.4% to close at $14.92 after LG Chem announced it will acquire AVEO Oncology for $15 per share in cash.
    • Zovio Inc (NASDAQ:ZVO) gained 38.7% to settle at $0.20 after declining 11% on Monday.
    • Digital Brands Group, Inc. (NASDAQ:DBGI) surged 35.3% to close at $0.1096.
    • Eqonex Limited (NASDAQ:EQOS) rose 35.1% to close at $0.3524.
    • Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) shares gained 32.5% to close at $8.16. Kiora Pharmaceuticals, on Monday, announced publication of Phase 1 trial results for KIO-100 as a treatment for ocular inflammatory disease.
    • Eargo, Inc. (NASDAQ:EAR) surged 30.5% to close at $0.89. Eargo was granted U.S. patent titled 'Hearing Device Test And Diagnostics System And Methods.'
    • Beyond Air, Inc. (NASDAQ:XAIR) gained 29.9% to close at $7.83. The company on Monday highlighted data from its LungFit GO pilot at-home study.
    • Decibel Therapeutics, Inc. (NASDAQ:DBTX) climbed 25.4% to close at $3.70. Decibel Therapeutics recently received FDA clearance of IND application for DB-OTO, a gene therapy product candidate designed to provide hearing to individuals with otoferlin-related hearing loss.
    • Oblong, Inc. (NASDAQ:OBLG) gained 25.1% to close at $0.45.
    • Mynaric AG (NASDAQ:MYNA) rose 24.8% to settle at $7.00. Mynaric will provide optical communications terminals to Northrop Grumman as part of the Space Development Agency's Tranche 1 Tracking Layer Program.
    • KULR Technology Group, Inc. (NASDAQ:KULR) gained 24.5% to close at $1.32. KULR Technology recently announced acquisition of VibeTech.
    • IMARA Inc. (NASDAQ:IMRA) gained 21.6% to close at $4.23. Enliven Therapeutics Inc and Imara recently agreed to merge in an all-stock transaction.
    • Novonix Limited (NASDAQ:NVX) rose 20.4% to close at $5.61.
    • Dolphin Entertainment, Inc. (NASDAQ:DLPN) surged 19.8% to close at $2.90.
    • IAMGOLD Corporation (NYSE:IAG) rose 19.8% to close at $1.27 after the company announced an agreement to sell its interest in Rosebel Gold Mines to Zijin Mining for cash consideration of $360 million.
    • Tenax Therapeutics, Inc. (NASDAQ:TENX) gained 18.3% to close at $0.1847.
    • ZeroFox Holdings, Inc. (NASDAQ:ZFOX) rose 16% to close at $4.87.
    • Ra Medical Systems, Inc. (NYSE:RMED) shares climbed 15.4% to close at $6.29. Ra Medical Systems raised $7.6 million through completed at-the-market facility.
    • Waldencast plc (NASDAQ:WALD) rose 15.4% to close at $9.69.
    • Golden Sun Education Group Limited (NASDAQ:GSUN) gained 14.7% to close at $21.90.
    • Legend Biotech Corporation (NASDAQ:LEGN) surged 14.2% to settle at $45.91.
    • Bright Minds Biosciences Inc. (NASDAQ:DRUG) gained 14% to close at $1.15.
    • Huadi International Group Co., Ltd. (NASDAQ:HUDI) climbed 12.3% to settle at $32.78.
    • Carnival Corporation (NYSE:CCL) rose 11.1% to close at $8.08 amid strength in cruise stocks. The company earlier announced a private offering of $1.25 billion aggregate principal amount of Senior Priority Notes due 2028.
    • Eterna Therapeutics Inc. (NASDAQ:ERNA) gained 11% to close at $5.46.
    • Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) rose 8.5% to close at $14.31.
    • NextPlay Technologies, Inc. (NASDAQ:NXTP) climbed 8.5% to close at $0.2170. NextPlay Technologies recently announced its NextBank secured a $200,000,000 revolving credit line facility.
    • Tremor International Ltd (NASDAQ:TRMR) rose 6.8% to close at $7.69 after gaining 9% on Monday.
    • Liquid Media Group Ltd. (NASDAQ:YVR) jumped 6.7% to close at $3.70 after the company announced Q3 sales were up year over year.

     


    Losers

    • Agrify Corporation (NASDAQ:AGFY) fell 58.6% to close at $4.43. Agrify said its Board of Directors approved a 1-for-10 reverse stock split.
    • Cosmos Holdings Inc. (NASDAQ:COSM) dropped 47.3% to close at $0.0790 on Tuesday after the company announced pricing of a $7.5 million upsized public offering at $0.12 per share.
    • Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) shares fell 45.2% to close at $2.7411 after the company announced a pause in new patient enrollment in its Phase 1/2 trial of seclidemstat in Ewing Sarcoma and FET-rearranged sarcomas following the death of a patient.
    • Inpixon (NASDAQ:INPX) fell 43.7% to close at $5.13. The company recently announced new purchase orders.
    • Sierra Metals Inc. (NYSE:SMTS) dropped 40.8% to close at $0.29 after the company provided a financial and operations update and announced a strategic review process.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) fell 28.1% to close at $1.61. AVCT reported a $10 million registered direct offering and concurrent private placement priced at-the-market under Nasdaq rules.
    • Statera Biopharma, Inc. (NASDAQ:STAB) shares fell 22.9% to close at $0.1655 after jumping 35% on Monday. Statera Biopharma announced signing of a binding MOU with Holobeam Technologies to gain access to Holobeam's disruptive diagnostic imaging and therapeutic technology for cancer patients.
    • Silvergate Capital Corporation (NYSE:SI) dropped 22.7% to close at $54.71 after the company reported worse-than-expected Q3 EPS and sales results.
    • FLJ Group Limited (NASDAQ:FLJ) fell 22.3% to close at $1.53.
    • Kalera Public Limited Company (NASDAQ:KAL) dropped 22.1% to close at $0.5530. Kalera intends to divest seed genetics business and international assets.
    • 9 Meters Biopharma, Inc. (NASDAQ:NMTR) fell 20.8% to close at $2.82. 9 Meters Biopharma announced a 1-for-20 reverse stock split.
    • Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) fell 20.3% to close at $7.64 after jumping 26% on Monday.
    • BOA Acquisition Corp. (NYSE:BOAS) dropped 20.2% to close at $7.90.
    • Akili, Inc. (NASDAQ:AKLI) fell 20% to close at $1.92.
    • RiceBran Technologies (NASDAQ:RIBT) fell 19.4% to close at $1.29.
    • Venus Acquisition Corporation (NASDAQ:VENA) fell 18.9% to close at $8.39.
    • Xtant Medical Holdings, Inc. (NYSE:XTNT) dropped 18.7% to close at $0.65.
    • Acorda Therapeutics, Inc. (NASDAQ:ACOR) shares fell 18.6% to close at $0.73. Acorda Therapeutics shares surged 164% on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.
    • D-Wave Quantum Inc. (NASDAQ:QBTS) dropped 15.4% to close at $5.23.
    • ServisFirst Bancshares, Inc. (NYSE:SFBS) fell 14% to close at $74.67 after the company reported worse-than-expected Q3 EPS results.
    • authID Inc. (NASDAQ:AUID) fell 12.1% to close at $1.45.
    • Vigil Neuroscience, Inc. (NASDAQ:VIGL) dropped 8.5% to close at $13.76.
    • Nuwellis, Inc. (NASDAQ:NUWE) shares fell 7.6% to close at $0.2772 after surging 15% on Monday. Nuwellis recently announced pricing of $9.6 million upsized underwritten public offering.
    Get the next $ACOR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACOR
    $AGFY
    $AKUS
    $AUID

    CompanyDatePrice TargetRatingAnalyst
    Eli Lilly and Company
    $LLY
    2/25/2026$1250.00Outperform
    RBC Capital Mkts
    Eli Lilly and Company
    $LLY
    2/20/2026$1350.00Overweight
    Barclays
    Norwegian Cruise Line Holdings Ltd.
    $NCLH
    2/13/2026$20.00Overweight → Neutral
    Analyst
    D-Wave Quantum Inc.
    $QBTS
    2/12/2026Buy
    TD Cowen
    Legend Biotech Corporation
    $LEGN
    2/12/2026$24.00Buy → Neutral
    Rothschild & Co Redburn
    Norwegian Cruise Line Holdings Ltd.
    $NCLH
    2/11/2026$23.00Overweight → Equal Weight
    Barclays
    Legend Biotech Corporation
    $LEGN
    1/22/2026$21.00Buy → Hold
    TD Cowen
    ServisFirst Bancshares Inc.
    $SFBS
    1/21/2026$89.00Neutral → Overweight
    Piper Sandler
    More analyst ratings

    $ACOR
    $AGFY
    $AKUS
    $AUID
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    May 31, 2024 - FDA Roundup: May 31, 2024

    For Immediate Release: May 31, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA approved mRESVIA (Respiratory Syncytial Virus Vaccine) for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. mRESVIA is an mRNA-based vaccine that is manufa

    5/31/24 3:22:42 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    May 7, 2024 - FDA Roundup: May 7, 2024

    For Immediate Release: May 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a meeting of the Psychopharmacologic Drugs Advisory Committee on June 4 to discuss a new drug application for midomafetamine (MDMA) capsules, submitted by Lykos Therapeutics, for the treatment of post-traumatic stress disorder. The committ

    5/7/24 4:10:24 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    December 5, 2023 - FDA Roundup: December 5, 2023

    For Immediate Release: December 05, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, registration opened for the FDA’s virtual Rare Disease Day on Friday, March 1, 2024. This year’s Rare Disease Day is dedicated to patients and health care professionals. Panels will discuss efforts to address the unique challenges with developing treat

    12/5/23 5:00:21 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACOR
    $AGFY
    $AKUS
    $AUID
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Quantum Computing Acceleration is Unlocking New Era of Autonomous Drone Efficiency

    NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Quantum computing is starting to play a meaningful role in improving how drones operate, especially when it comes to planning and real-time decision-making. Drone missions involve thousands of moving parts — weather, airspace rules, terrain, battery life, payload weight, and changing objectives. Traditional computers process these variables step by step, which can slow things down as operations scale. Quantum computing, however, is designed to evaluate many possibilities at once, helping operators find faster, more efficient routes and better mission plans. For investors, that means lower operating costs, fas

    2/26/26 9:45:00 AM ET
    $IONQ
    $QBTS
    $QUBT
    EDP Services
    Technology
    Computer Software: Prepackaged Software

    NETHERTON NOW Recognizes Rare Disease Day and Highlights Growing Global Awareness of Netherton Syndrome

    ASHBURN, Va., Feb. 26, 2026 (GLOBE NEWSWIRE) -- In recognition of Rare Disease Day® 2026, Quoin Pharmaceuticals Ltd. (NASDAQ:QNRX) today highlighted the continued growth of its NETHERTON NOW awareness campaign, which seeks to amplify the voices of patients, caregivers and clinicians impacted by Netherton Syndrome, a rare genetic disease with no approved treatment or cure. Rare Disease Day, observed annually on the last day of February during Rare Disease Month, was established in 2008 by EURORDIS to raise awareness of rare conditions and the profound challenges faced by those living with them. While each rare disease affects a relatively small population, collectively rare diseases impact

    2/26/26 8:30:00 AM ET
    $QNRX
    Medical/Dental Instruments
    Health Care

    authID Selected by Point of Sale Lender to Provide Fraud Prevention and Identity Assurance

    New fintech customer win highlights authID's growing leadership in biometric identity verification for consumer retail financing DENVER, Feb. 26, 2026 (GLOBE NEWSWIRE) --  authID (NASDAQ:AUID), a leading provider of biometric identity verification and authentication solutions, today announced that a U.S. point-of-sale lending and payment financing platform has selected authID to protect its merchant onboarding, consumer origination, and account access workflows from escalating identity fraud. The selection of authID underscores growing momentum for biometric identity assurance in consumer finance, as fintech platforms confront rising identity fraud, organized fraud rings, and account tak

    2/26/26 8:00:00 AM ET
    $AUID
    Computer Software: Prepackaged Software
    Technology

    $ACOR
    $AGFY
    $AKUS
    $AUID
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer O'Dowd William Iv bought $4,950 worth of shares (3,000 units at $1.65), increasing direct ownership by 0.68% to 440,990 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    2/24/26 7:08:09 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    Chief Executive Officer O'Dowd William Iv bought $4,851 worth of shares (3,300 units at $1.47), increasing direct ownership by 0.76% to 437,990 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    2/17/26 5:36:47 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    Chief Executive Officer Siokas Grigorios bought $145,000 worth of shares (388,532 units at $0.37), increasing direct ownership by 5% to 8,861,914 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/13/26 10:05:37 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    $ACOR
    $AGFY
    $AKUS
    $AUID
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital Mkts initiated coverage on Eli Lilly with a new price target

    RBC Capital Mkts initiated coverage of Eli Lilly with a rating of Outperform and set a new price target of $1,250.00

    2/25/26 7:51:49 AM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Barclays initiated coverage on Eli Lilly with a new price target

    Barclays initiated coverage of Eli Lilly with a rating of Overweight and set a new price target of $1,350.00

    2/20/26 8:24:27 AM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Norwegian Cruise Line downgraded by Analyst with a new price target

    Analyst downgraded Norwegian Cruise Line from Overweight to Neutral and set a new price target of $20.00

    2/13/26 8:29:21 AM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    $ACOR
    $AGFY
    $AKUS
    $AUID
    SEC Filings

    View All

    Nuwellis Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Nuwellis, Inc. (0001506492) (Filer)

    2/26/26 8:49:40 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    D-Wave Quantum Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - D-Wave Quantum Inc. (0001907982) (Filer)

    2/26/26 7:02:18 AM ET
    $QBTS
    EDP Services
    Technology

    SEC Form 20-F filed by NOVONIX Limited

    20-F - NOVONIX Ltd (0001859795) (Filer)

    2/25/26 9:17:49 PM ET
    $NVX
    Industrial Machinery/Components
    Miscellaneous

    $ACOR
    $AGFY
    $AKUS
    $AUID
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP & CFO Kempa Mark was granted 132,100 shares, increasing direct ownership by 36% to 501,452 units (SEC Form 4)

    4 - Norwegian Cruise Line Holdings Ltd. (0001513761) (Issuer)

    2/25/26 4:17:54 PM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    EVP, Chief Vessel Ops & NO Dahlgren Patrik was granted 90,252 shares, increasing direct ownership by 62% to 235,069 units (SEC Form 4)

    4 - Norwegian Cruise Line Holdings Ltd. (0001513761) (Issuer)

    2/25/26 4:17:15 PM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    EVP GC, CDO & Sec'y Farkas Daniel S was granted 132,100 shares, increasing direct ownership by 42% to 447,367 units (SEC Form 4)

    4 - Norwegian Cruise Line Holdings Ltd. (0001513761) (Issuer)

    2/25/26 4:15:13 PM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    $ACOR
    $AGFY
    $AKUS
    $AUID
    Financials

    Live finance-specific insights

    View All

    D-Wave Reports Fourth Quarter and Year-End 2025 Results

    FY 2025 Revenue Increased 179% Year over Year FY 2025 Gross Profit Increased 265% Year over Year Ended 2025 With Highest Liquidity Position in Company's History at over $884 Million D-Wave Quantum Inc. (NYSE:QBTS) ("D-Wave" or the "Company"), the only dual-platform quantum computing company, providing both annealing and gate-model systems, software, and services, today announced financial results for its fiscal fourth quarter and year ended December 31, 2025. "Our 2025 results mark one of the most successful and transformative years in D-Wave's history, with meaningful growth across every key business metric — revenue, Bookings, technical milestones, and scientific breakthroughs," s

    2/26/26 7:00:00 AM ET
    $QBTS
    EDP Services
    Technology

    Nuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026

    MINNEAPOLIS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced that it will release financial results for the fourth quarter and full year 2025 on March 10, 2026. Nuwellis will host a conference call and webcast at 9:00 AM ET to discuss its financial results and provide a general business update. To access the live webcast, please visit the Investors page of the Nuwellis website at https://ir.nuwellis.com. Alternatively, you may access the live conference call by dialing 1-800-343-4885 (U.S) or 1-203-518-9851 (international) and using the conference ID: N

    2/24/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2025 Results

    SOMERSET, N.J., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ:LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Tuesday, March 10, 2026, to review fourth-quarter and full-year 2025 financial results. During the conference call and accompanying webcast, senior management will provide an overview of quarterly and full-year financial performance. Investors and other interested parties may access the live audio webcast via this weblink. A replay of the webcast, along with the earnings press release, will be available in the Investor Relations section of the Legend Biotech website under Events and Presen

    2/24/26 8:00:00 AM ET
    $LEGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACOR
    $AGFY
    $AKUS
    $AUID
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Agrify Corporation

    SC 13D/A - Agrify Corp (0001800637) (Subject)

    11/29/24 4:30:03 PM ET
    $AGFY
    Farming/Seeds/Milling
    Consumer Staples

    Amendment: SEC Form SC 13D/A filed by Agrify Corporation

    SC 13D/A - Agrify Corp (0001800637) (Subject)

    11/29/24 4:30:03 PM ET
    $AGFY
    Farming/Seeds/Milling
    Consumer Staples

    Amendment: SEC Form SC 13G/A filed by D-Wave Quantum Inc.

    SC 13G/A - D-Wave Quantum Inc. (0001907982) (Subject)

    11/15/24 7:37:26 AM ET
    $QBTS
    EDP Services
    Technology

    $ACOR
    $AGFY
    $AKUS
    $AUID
    Leadership Updates

    Live Leadership Updates

    View All

    Nuwellis Appoints David A. McDonald and Martin J. Emerson to Board of Directors

    MINNEAPOLIS, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced the appointment of David A. McDonald and Martin J. Emerson to its Board of Directors, effective February 24, 2026. The appointments strengthen the Company's board with complementary expertise in public company leadership, capital markets, and medical device commercialization. "These appointments reflect our continued focus on operational discipline and long-term value creation," said John Erb, President and CEO of Nuwellis. "Marty has led multiple medical device organizations through scali

    2/26/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board

    CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its Advisory Board, where he will support the Company's biotechnology initiatives, with a focus on AI-driven drug discovery and clinical-stage therapeutic development. Dr. Iliopoulos is a world-renowned expert in artificial intelligence, drug discovery, and drug development. He currently serves as Co-Founder and CEO of Athos Therapeutics Inc., an AI software and clinical-stage biotechnology company focused on developing precision therapeutics for autoimmun

    2/24/26 12:30:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    D-Wave Joins Southeastern Quantum Collaborative as Inaugural Member

    D-Wave Quantum Inc. (NYSE:QBTS) ("D-Wave" or the "Company"), the only dual-platform quantum computing company, providing both annealing and gate-model systems, software and services, today joined the Southeastern Quantum Collaborative (SQC) as an inaugural member, along with The University of Alabama in Huntsville, Davidson Technologies, IBM and Alabama A&M University. The SQC will bring together academia, industry and government to accelerate the advancement and application of quantum information science and technology across the Southeast. In addition, it aims to develop the quantum-ready workforce needed to commercialize the technology. Given Davidson hosts a D-Wave Advantage2TM system

    2/19/26 7:00:00 AM ET
    $QBTS
    EDP Services
    Technology